1. Home
  2. NWGL vs LSTA Comparison

NWGL vs LSTA Comparison

Compare NWGL & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • LSTA
  • Stock Information
  • Founded
  • NWGL 2008
  • LSTA 1980
  • Country
  • NWGL Macau
  • LSTA United States
  • Employees
  • NWGL N/A
  • LSTA N/A
  • Industry
  • NWGL
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • NWGL
  • LSTA Health Care
  • Exchange
  • NWGL Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • NWGL 22.8M
  • LSTA 20.9M
  • IPO Year
  • NWGL 2023
  • LSTA N/A
  • Fundamental
  • Price
  • NWGL $1.17
  • LSTA $2.09
  • Analyst Decision
  • NWGL
  • LSTA Strong Buy
  • Analyst Count
  • NWGL 0
  • LSTA 2
  • Target Price
  • NWGL N/A
  • LSTA $23.50
  • AVG Volume (30 Days)
  • NWGL 14.9K
  • LSTA 144.6K
  • Earning Date
  • NWGL 11-29-2025
  • LSTA 11-06-2025
  • Dividend Yield
  • NWGL N/A
  • LSTA N/A
  • EPS Growth
  • NWGL N/A
  • LSTA N/A
  • EPS
  • NWGL N/A
  • LSTA N/A
  • Revenue
  • NWGL $21,539,347.00
  • LSTA $1,070,000.00
  • Revenue This Year
  • NWGL N/A
  • LSTA N/A
  • Revenue Next Year
  • NWGL N/A
  • LSTA N/A
  • P/E Ratio
  • NWGL N/A
  • LSTA N/A
  • Revenue Growth
  • NWGL N/A
  • LSTA N/A
  • 52 Week Low
  • NWGL $0.91
  • LSTA $1.87
  • 52 Week High
  • NWGL $6.61
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 36.57
  • LSTA 35.02
  • Support Level
  • NWGL $1.30
  • LSTA $2.00
  • Resistance Level
  • NWGL $1.48
  • LSTA $2.98
  • Average True Range (ATR)
  • NWGL 0.12
  • LSTA 0.23
  • MACD
  • NWGL -0.05
  • LSTA -0.05
  • Stochastic Oscillator
  • NWGL 3.33
  • LSTA 9.18

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: